12TH ADRIATIC AND 8TH CROATIAN CONGRESS OF PHARMACOECONOMICS AND OUTCOMES RESEARCH WITH FOCUS ON CEE

LOVRAN, CROATIA 18-20 APRIL 2024

Dear Colleague,

It is our great pleasure to invite you to participate in the 12th Adriatic and 8th Croatian Congress of Pharmacoeconomics and Outcomes Research with focus on CEE countries, which will be held at the conference centre of Hotel Excelsior in Lovran, Croatia, on April 18-20, 2024, and will be organized by the Section for Pharmacoeconomics and Outcomes Research of the Croatian Society of Clinical Pharmacology and Therapeutics, Croatian Physician Association.

The main objective of this year’s congress is to intensify and enhance professional and scientific discussions and collaboration between various stakeholders on the following topic:

After several years during which we had been focusing to problem identification, assessment, and measurement, mostly around patient access and equity rights to innovation, and identifying the gaps to more developed EU countries, the main goal of past few congresses was to focus on finding solutions and this year’s congress will try to achieve the same goal.

During our 14 years journey, the knowledge, capacity, and experience of CEE countries to identify and implement solutions have improved, both at Academia and Government from one side to Health Technology Industry on the other side. Additionally, and most importantly, Patient’s capacity to be involved and consulted in this process have also significantly improved, so we believe all pre-requisites have now been met to start focusing on the implementation and monitoring of the optimal solutions across priority disease areas, for which we need all relevant stakeholders to be at the same table and working against the same, Patient Outcomes’ focused goals.

In addition to the main congress theme, these are the sub-topics of this year’s congress:

•    Access to Innovation, Value, and Equity in Healthcare Decision Making
•    Implementation Readiness for Emerging EU Legislation Changes
•    Real World Data and Information Systems
•    National Patient Access Policy Challenges
•    Alternative Pricing Arrangements as an Opportunity for Broader Access to ATMPs
•    Developing and Successfully Implementing Health Technology Management (HTM) Processes Following a Drug Reimbursement Decision.

However, the full congress agenda will also comprise other important topics, such as development of healthcare policies, pharmaceutical pricing and reimbursement, comparative efficacy studies, outcomes research, value of health and health interventions, and many others. Preliminary program is attached for your reference.

Our Congress has established itself as the forum (i) to share research and help advance the science of health economics within the Adriatic and CEE region, (ii) to give opportunity for networking and interacting, and (iii) to get involved in debating controversial and complex issues of the health care involving a range of stakeholders. We are proud that during the past 10 years our annual Congress has become a reference point in the field of Pharmacoeconomics and Outcomes Research in our region since we are not shying away from explicitly discussing pressing challenges, such as conditions of severe economic constraints within our jurisdictions.

We encourage your participation by submitting research podium and poster papers. As every year, we will organize several plenary sessions, round table discussion, issue panels, and research presentations.

It is important to note that we, as the organizers, will ensure participation of a wide range of stakeholders within the health care: the healthcare professionals (local, regional and international), members of academia, different associations, regulatory and payer authorities, politicians, and last but not least the pharmaceutical industry.

The overarching goal of the Congress is to advance public health care policies in order to maximize societal welfare and optimize diffusion of and access to innovative health care technologies, so that patients can reach their full life and health potential.

The congress’ technical organisation is entrusted to a long-term partner Otours PCO. You will shortly receive additional information about the sponsorship options in a separate email sent by Otours PCO team. In the meantime, should you have any preliminary questions, please contact Ms Tatjana Koprtla (tatjana.koprtla@otours.hr).

If you find this program of your scientific and professional interest, we would highly appreciate and value your kind sponsorship through one of the following Sponsorship Options:


GOLD SPONSOR

- is entitled to receive:

1.    Publication of Company’s name and logo, in the group of Gold Sponsors, on all Congress information materials published after the receipt of sponsorship payment;
2.    Large Company logo, published next to the Congress name and main topic, on all official Congress posters;
3.    Company name published by means of LCD projection, in the group of Gold Sponsors, during opening and closing ceremonies, before and after all presentation sessions, and during coffee breaks.
4.    One Corporate promotional page in the final Congress Programme
5.    One Corporate promotional page in the Congress Abstract book
6.    Large Company logo on all other official congress written materials
7.    Two free registrations for the congress attendance
8.    Suggestion of three topics of interest to be covered during the congress, one of which will be chosen by Congress Scientific Committee for the inclusion in Congress Final Programme.
9.    Short address at the Congress Opening ceremony (5 min)

The opportunity to be presented as a Gold Sponsor can be ensured by timely sponsorship payment of 8.500,00 EUR (VAT excluded).



SILVER SPONSOR

- is entitled to receive:

1.    Publication of Company’s name and logo, in the group of Silver Sponsors, on all Congress information materials published after the receipt of sponsorship payment;
2.    Medium Company logo, published next to the Congress name and main topic, on all official Congress posters;
3.    Company name published by means of LCD projection, in the group of Silver Sponsors, during opening and closing ceremonies, before and after all presentation sessions, and during coffee breaks.
4.    Half Corporate promotional page in the final Congress Programme
5.    Half Corporate promotional page in the Congress Abstract book
6.    Medium Company logo on all other official congress written materials
7.    One free registration for the congress attendance

The opportunity to be presented as a Silver Sponsor can be ensured by timely sponsorship payment of 6.000,00 EUR (VAT excluded).


BRONZE SPONSOR

- is entitled to receive:

1.    Publication of Company’s name and logo, in the group of Bronze Sponsors, on all Congress information materials published after the receipt of sponsorship payment;
2.    Small Company logo, published next to the Congress name and main topic, on all official Congress posters;
3.    Company name published by means of LCD projection, in the group of Bronze Sponsors, during opening and closing ceremonies, before and after all presentation sessions, and during coffee breaks.
4.    One quarter of Corporate promotional page in the final Congress Programme
5.    One quarter of Corporate promotional page in the Congress Abstract book.

The opportunity to be presented as a Bronze Sponsor can be ensured by timely sponsorship payment of 3.500,00 EUR (VAT excluded).

CONGRESS CONTRIBUTORS
- is entitled to receive:

1.    Company name published by means of LCD projection, in the group of Bronze Sponsors, during opening and closing ceremonies, before and after all presentation sessions, and during coffee breaks.

The opportunity to be presented as a Congress Contributor can be ensured by timely sponsorship payment of amounts between 1.000 - 3.399,00 EUR (VAT excluded).

Please make sure to confirm your sponsorship package by Feb 28, 2024

For any further information please contact Congress Technical Organizers:
OTOURS PCO d.o.o.: Gajeva 1, Zagreb, Croatia; Phone: +385.1.4831.444 / Mobile phone: +385.(0).98.9805.716. Contact person: Tatjana Koprtla, tatjana.koprtla@otours.hr; pharmacoeconomics@otours.hr

Sincerely,

Prof. Dinko Vitezić, MD, PhD

Congress Chair

President, Section for Pharmacoeconomics and Outcomes Research Croatian Society for Clinical Pharmacology and Therapeutics

 Download this document in PDF format here.